2014
DOI: 10.5966/sctm.2013-0205
|View full text |Cite
|
Sign up to set email alerts
|

Cholesterol and Hematopoietic Stem Cells: Inflammatory Mediators of Atherosclerosis

Abstract: Recent findings have provided new insight into the interaction among hematopoietic stem cells (HSPCs), cholesterol, and atherosclerosis. The authors review studies in mice and consider the connection in humans between cholesterol and HSPCs. Recent studies represent an important avenue to determine whether the biology of humans is the same and whether antagonism of HSPC mobilization and differentiation in response to cholesterol is of benefit for prevention and regression of atherosclerosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
16
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 27 publications
1
16
0
Order By: Relevance
“…Small animal model studies clearly show the effects of disease on the levels of HSC and HSPC populations including myocardial infarction , stroke , hypercholesterolemia , aging , and cancer . In human subjects, CD34+ Lineage‐ CD45dim cells in the blood stream correlate with total cholesterol levels , consistent with studies in small animal models of hypercholesterolemia.…”
supporting
confidence: 70%
See 1 more Smart Citation
“…Small animal model studies clearly show the effects of disease on the levels of HSC and HSPC populations including myocardial infarction , stroke , hypercholesterolemia , aging , and cancer . In human subjects, CD34+ Lineage‐ CD45dim cells in the blood stream correlate with total cholesterol levels , consistent with studies in small animal models of hypercholesterolemia.…”
supporting
confidence: 70%
“…However, more precise distinction of the subtypes of CD34+ cells in the blood stream of humans has not been performed. Mechanistically, HSCs and HSPCs play key roles in progression of atherosclerosis and cancer in animal models by contributing to regeneration of myeloid lineage cells, monocytes, and neutrophils among others. Development of methods to measure HSCs and HSPCs in venous blood of human subjects would be a key advance to realize translation of animal model findings to convenient measurements in patients with disease, avoiding or supplementing information from bone marrow samples.…”
mentioning
confidence: 99%
“…21 IL-6 and TNF-a are classic proinflammatory cytokines to promote AS, whereas IL-4 is an anti-inflammatory cytokine. 22 It appears to be a promising strategy for AS treatment by reducing circulating IL-6 and TNF-a.…”
Section: Discussionmentioning
confidence: 99%
“…This is consistent with recent work from our lab indicating that DIO promotes colonic Lgr5 + stem cell expansion during cancer initiation (DeClercq et al, 2015). Interestingly, the inactivation of cholesterol efflux transporters (ABCA1 and ABCG1) increase the number of circulating hematopoietic stem cells (HSPCs) (Feng et al, 2012; Gomes et al, 2010; Yvan-Charvet et al, 2007) and activate inflammatory cells (Lang and Cimato, 2014), suggesting that the accumulation of cellular membrane cholesterol may directly regulate aspects of stem cell biology. From a mechanistic perspective, the Wnt/β-catenin pathway maintains a stem cell/progenitor phenotype in many cell types (Pinto and Clevers, 2005).…”
Section: Membrane Cholesterol and Stem Cellsmentioning
confidence: 99%